Large ischemic core defined by visually assessed ASPECTS predicts functional outcomes comparably accurate to automated CT perfusion in the 6-24 h window
View abstract on PubMed
Summary
This summary is machine-generated.Visually assessed Non-contrast CT Alberta Stroke Program Early CT Scores (ASPECTS) are as effective as automated CT perfusion (aCTP) in predicting outcomes for large vessel occlusion stroke patients. This finding supports using ASPECTS for treatment selection in anterior circulation large vessel occlusion (aLVO).
Area Of Science
- Neurology
- Radiology
- Stroke Medicine
Background
- Automated CT perfusion (aCTP) is standard for selecting anterior circulation large vessel occlusion (aLVO) patients for endovascular treatment (EVT).
- The predictive accuracy of visually assessed Non-contrast CT Alberta Stroke Program Early CT Scores (ASPECTS) versus aCTP for functional outcomes is not well-established.
Purpose Of The Study
- To compare the accuracy of visually assessed ASPECTS and aCTP in predicting favorable functional outcomes in aLVO patients.
- To evaluate the association between these imaging modalities and functional outcomes at 3 months post-stroke.
Main Methods
- Retrospective analysis of 210 aLVO patients from the Swiss Stroke Registry (2014-2021) treated with EVT or best medical treatment.
- ASPECTS assessed visually on non-contrast CT; ischemic core volumes assessed on aCTP.
- Logistic regression and ROC curve analysis used to compare predictive accuracy for favorable outcomes (modified Rankin Scale [mRS] 0-2) at 3 months.
Main Results
- Visually assessed ASPECTS, but not aCTP core volumes, were significantly associated with favorable functional outcomes (acOR 1.85, P=0.001).
- ROC analysis revealed comparable diagnostic accuracy for both modalities (ASPECTS: 0.80 vs. aCTP core: 0.79).
Conclusions
- Visually assessed ASPECTS demonstrate comparable, if not superior, accuracy to automated CT perfusion core volumes in predicting functional outcomes for aLVO patients.
- ASPECTS remains a valuable tool for guiding treatment decisions in aLVO stroke management.

